Clover Health Achieves First-Ever Positive GAAP Net Income in Q1, Reports $749M Revenue
CLOV sits 77% above its 52-week low of $1.58.
Summary
Clover Health reported robust first-quarter 2026 results, achieving its first-ever positive GAAP Net Income of $27.33 million, translating to diluted EPS of $0.05. The company also posted strong revenue of $749.19 million, marking a 62% year-over-year increase. This detailed earnings report follows the 8-K and 10-Q filings on May 6th and May 8th, respectively, which broadly announced strong Q1 results and the achievement of positive GAAP Net Income. The specific financial figures provided in this summary are crucial for traders to assess the magnitude of the company's improved financial performance. Investors will now focus on the company's ability to sustain this profitability and continued growth in membership and revenue.
At the time of this announcement, CLOV was trading at $2.79 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $1.58 to $3.92. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.